NO20030794L - Method of drug delivery to hepatocytes of flavivirida infections - Google Patents

Method of drug delivery to hepatocytes of flavivirida infections

Info

Publication number
NO20030794L
NO20030794L NO20030794A NO20030794A NO20030794L NO 20030794 L NO20030794 L NO 20030794L NO 20030794 A NO20030794 A NO 20030794A NO 20030794 A NO20030794 A NO 20030794A NO 20030794 L NO20030794 L NO 20030794L
Authority
NO
Norway
Prior art keywords
flavivirida
hepatocytes
infections
drug delivery
drug
Prior art date
Application number
NO20030794A
Other languages
Norwegian (no)
Other versions
NO20030794D0 (en
Inventor
Lau Johnson
Zhi Hong
Original Assignee
Ribapharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribapharm Inc filed Critical Ribapharm Inc
Publication of NO20030794D0 publication Critical patent/NO20030794D0/en
Publication of NO20030794L publication Critical patent/NO20030794L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20030794A 2000-08-22 2003-02-20 Method of drug delivery to hepatocytes of flavivirida infections NO20030794L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22686900P 2000-08-22 2000-08-22
US24062700P 2000-10-13 2000-10-13
PCT/US2001/026057 WO2002015904A1 (en) 2000-08-22 2001-08-21 Methods of drug delivery to hepatocytes and treatment of flaviviridae infections

Publications (2)

Publication Number Publication Date
NO20030794D0 NO20030794D0 (en) 2003-02-20
NO20030794L true NO20030794L (en) 2003-04-22

Family

ID=26920944

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030794A NO20030794L (en) 2000-08-22 2003-02-20 Method of drug delivery to hepatocytes of flavivirida infections

Country Status (15)

Country Link
EP (1) EP1313469A1 (en)
JP (1) JP2004506684A (en)
KR (1) KR20030040416A (en)
CN (1) CN1447692A (en)
AU (1) AU2001292557A1 (en)
BR (1) BR0113388A (en)
CA (1) CA2415793A1 (en)
CZ (1) CZ2003308A3 (en)
HU (1) HUP0302884A2 (en)
IL (1) IL154167A0 (en)
MX (1) MXPA03001529A (en)
NO (1) NO20030794L (en)
PL (1) PL365744A1 (en)
RU (1) RU2003102607A (en)
WO (1) WO2002015904A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003037908A1 (en) * 2001-10-31 2003-05-08 Ribapharm Inc. Antiviral combination therapy and compositions
US7608258B2 (en) 2002-04-13 2009-10-27 Allan Mishra Method for treatment of tendinosis using platelet rich plasma
US6811777B2 (en) 2002-04-13 2004-11-02 Allan Mishra Compositions and minimally invasive methods for treating incomplete connective tissue repair
US20050182252A1 (en) 2004-02-13 2005-08-18 Reddy K. R. Novel 2'-C-methyl nucleoside derivatives
WO2010042658A1 (en) 2008-10-07 2010-04-15 Bioparadox, Llc Use of platelet rich plasma composition in the treatment of cardiac conduction abnormalities
US20140356893A1 (en) 2013-06-04 2014-12-04 Allan Mishra Compositions and methods for using platelet-rich plasma for drug discovery, cell nuclear reprogramming, proliferation or differentiation
EP3105238A4 (en) 2014-02-13 2017-11-08 Ligand Pharmaceuticals, Inc. Prodrug compounds and their uses
EP3164136A4 (en) 2014-07-02 2018-04-04 Ligand Pharmaceuticals, Inc. Prodrug compounds and uses therof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3984396A (en) * 1971-06-01 1976-10-05 Icn Pharmaceuticals, Inc. 1-(β,-D-ribofuranosyl)-1,2,4-triazole acid esters
US5959077A (en) * 1993-05-26 1999-09-28 Laboratori Balducci S.P.A. Hepatotropic conjugates of antiviral drugs carriers thereof and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
KR20030040416A (en) 2003-05-22
WO2002015904B1 (en) 2002-07-04
HUP0302884A2 (en) 2003-12-29
WO2002015904A1 (en) 2002-02-28
PL365744A1 (en) 2005-01-10
IL154167A0 (en) 2003-07-31
EP1313469A1 (en) 2003-05-28
NO20030794D0 (en) 2003-02-20
AU2001292557A1 (en) 2002-03-04
CA2415793A1 (en) 2002-02-28
MXPA03001529A (en) 2004-04-02
JP2004506684A (en) 2004-03-04
BR0113388A (en) 2004-02-25
CZ2003308A3 (en) 2004-03-17
CN1447692A (en) 2003-10-08
RU2003102607A (en) 2004-07-27

Similar Documents

Publication Publication Date Title
CY2013011I1 (en) METHOD OF ADMINISTRATION OF DIPHOSPHONICS
NO20031165L (en) Preparation for transdermal delivery of fentanyl
NO20030627D0 (en) Hydrogel-driven drug dosage form
PT1253932E (en) PHARMACEUTICAL COMPOUNDS OF BOTULINIC TOXIN
DK1381351T3 (en) Process for Continuous Preparation of Inhalable Medications
NO20022970L (en) Hydrogel-driven drug dosage form
NO20025592L (en) Continuous production of pharmaceutical granulation
NO20003968L (en) Pharmaceutical preparations
ATE334662T1 (en) PRODUCTION PROCESS OF MEDICINAL PREPARATIONS
EE200300103A (en) Method of contraception and the form of contraception to be administered
DK1208864T3 (en) Improvements to drug delivery devices
EE200200393A (en) Pharmaceutical composition of glyburide
IS6521A (en) Method of purifying fermentation extract
ITMO20030201A1 (en) SYSTEM OF INFUSION OF PHARMACOLOGICAL SOLUTIONS
ATE311173T1 (en) NEW SELF-EMULSIFIING DRUG DELIVERY SYSTEM
NO20026212D0 (en) Compound for drug delivery system and method of preparation of the compound
NO20030794L (en) Method of drug delivery to hepatocytes of flavivirida infections
EE200300501A (en) Formulations of imidazotriazinone for nasal administration
DK1225902T3 (en) Ciclesonide-containing pharmaceutical composition for administration to the mucosa
IS7958A (en) Process for the preparation of methyl 2-diphenylmethylsulfinyl acetate
DK1326836T3 (en) Process for Preparation of 3-Amino-2-chloro-4-methylpyridine
EE200100544A (en) 15-membered 8α-and 9α-lactams, their method of preparation and pharmaceutical composition
DE60111459D1 (en) PREPARATIONS FOR THE TRANSDERMAL ADMINISTRATION OF HYDROPHILIC SUBSTANCES
DK1591122T3 (en) Process for administration of bisphosphonates
DK1404341T3 (en) Combination of active substances for pharmacological therapy of nicotine dependence

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application